Sandoz to Pay Nearly $480 Million to Settle US Antitrust Lawsuits

Swiss pharmaceutical company Sandoz has agreed to pay approximately $480 million to resolve long-standing antitrust litigation in the United States. The settlement addresses allegations of price-fixing and other anti-competitive practices.

3 Aug, 07:02 — 3 Aug, 07:02

Post Share

Sources

Showing 1 of 2 sources

wsjHigh3h ago

Sandoz to Pay Around $480 Million to Settle U.S. Antitrust Pricing Litigations - WSJ

Sandoz to Pay Around $480 Million to Settle U.S. Antitrust Pricing Litigations WSJ

Read full article →

Coverage Timeline

First report: wsj · 3 Aug, 07:02|Full coverage: 2 · 3m|Window: 3m

Left-leaningCenterRight-leaning

wsj3 Aug, 07:02First to report

Sandoz to Pay Around $480 Million to Settle U.S. Antitrust Pricing Litigations - WSJ

swissinfo3 Aug, 07:05Latest update

PERSPECTA

PERSPECTA

Sandoz to Pay Nearly $480 Million to Settle US Antitrust Lawsuits

Sources

Sandoz to Pay Around $480 Million to Settle U.S. Antitrust Pricing Litigations - WSJ

Coverage Timeline

Sandoz to Pay Around $480 Million to Settle U.S. Antitrust Pricing Litigations - WSJ

Swiss pharma firm Sandoz to pay $450 million in US antitrust suit - SWI swissinfo.ch

Related Stories

Audit Reveals Irregularities in Philippine VP's Confidential Funds

Nigerian Works Minister Umahi Dismisses Sack Calls, Cites Tinubu's Directive

Abducted Kebbi High Court Judge Regains Freedom

Romanian PSD Calls for Urgent Restart of Coal Power Plants

PERSPECTA